We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Nutrien (NTR) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates
Read MoreHide Full Article
Nutrien (NTR - Free Report) reported $10.81 billion in revenue for the quarter ended June 2026, representing a year-over-year increase of 3.6%. EPS of $2.61 for the same period compares to $2.65 a year ago.
The reported revenue compares to the Zacks Consensus Estimate of $10.67 billion, representing a surprise of +1.31%. The company delivered an EPS surprise of -3.33%, with the consensus EPS estimate being $2.70.
While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.
As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.
Here is how Nutrien performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:
Potash - Sales volumes - Total: 3,943.00 KTon compared to the 4,039.88 KTon average estimate based on three analysts.
Nitrogen - Sales volumes - Total: 2,253.00 KTon versus the three-analyst average estimate of 2,352.95 KTon.
Phosphate - Average net selling price - Industrial and feed: 919.00 $/Ton versus the three-analyst average estimate of 911.01 $/Ton.
Phosphate - Average net selling price - Fertilizer: 719.00 $/Ton compared to the 726.95 $/Ton average estimate based on three analysts.
Net Sales- Downstream- Retail: $8.27 billion versus the five-analyst average estimate of $8.15 billion. The reported number represents a year-over-year change of +3.9%.
Total Sales- Upstream and Midstream- Nitrogen: $1.27 billion versus $1.25 billion estimated by five analysts on average. Compared to the year-ago quarter, this number represents a -9.9% change.
Total Sales- Upstream and Midstream- Potash: $1.14 billion compared to the $1.14 billion average estimate based on five analysts. The reported number represents a change of +4.6% year over year.
Total Sales- Upstream and Midstream- Phosphate: $525 million versus $522.55 million estimated by five analysts on average. Compared to the year-ago quarter, this number represents a +16.9% change.
Retail sales by product line- Crop protection products: $2.76 billion versus the three-analyst average estimate of $2.71 billion. The reported number represents a year-over-year change of +3.3%.
Potash sales by geography- Manufactured product- Offshore: $781 million versus $762.8 million estimated by three analysts on average. Compared to the year-ago quarter, this number represents a +11.4% change.
Retail sales by product line- Crop nutrients: $3.54 billion compared to the $3.25 billion average estimate based on three analysts. The reported number represents a change of +4.4% year over year.
Net Sales- Eliminations: $-424 million versus $-389.43 million estimated by three analysts on average. Compared to the year-ago quarter, this number represents a +3.7% change.
Shares of Nutrien have returned +2.5% over the past month versus the Zacks S&P 500 composite's +3.5% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.
View the Zacks #1 Rank List
Image: Bigstock
Nutrien (NTR) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates
Nutrien (NTR - Free Report) reported $10.81 billion in revenue for the quarter ended June 2026, representing a year-over-year increase of 3.6%. EPS of $2.61 for the same period compares to $2.65 a year ago.
The reported revenue compares to the Zacks Consensus Estimate of $10.67 billion, representing a surprise of +1.31%. The company delivered an EPS surprise of -3.33%, with the consensus EPS estimate being $2.70.
While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.
As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.
Here is how Nutrien performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:View all Key Company Metrics for Nutrien here>>>
Shares of Nutrien have returned +2.5% over the past month versus the Zacks S&P 500 composite's +3.5% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.